Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Adenosine 5'-triphosphate

Phase 1Small molecule

MMaastricht University Medical Center

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

Cough

NCT07085975

Clinical

Trials by Indication[1]

Infusion1 trial

Application of ATP Infusions in Palliative Home Care

Completed·MMaastricht University Medical Center·Phase 3·NCT00565188·100 enrolled

Cough1 trial

The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges

Recruiting·MMcMaster University·Phase 1·NCT07085975·33 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Adenosine 5'-triphosphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Adenosine 5'-triphosphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Adenosine 5'-triphosphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Maastricht University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: MMaastricht University Medical Center

Related News